Adhera Therapeutics, Inc. Intellectual Property Contracts & Agreements

15 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Second Addendum to the License Agreement
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2022
Addendum to License Agreement Adhera Therapeutics, Inc. and Melior Pharmaceuticals I, LLC dated August 20, 2021 dated February 16, 2022
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2022
License Agreement between Adhera Therapeutics, Inc. and Melior Pharmaceuticals I, LLC dated August 20, 2021
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2022
License Agreement
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
PA
2021
License Agreement dated July 17, 2017 between Marina Biotech, Inc. and Oncotelic, Inc
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2017
AMENDMENT No. 2 to LICENSE AGREEMENT
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2015
INTELLECTUAL PROPERTY LICENSE AGREEMENT
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2012
AMENDMENT NO. 1TO RESEARCH AND LICENSE AGREEMENT
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2012
EXCLUSIVE LICENSE AGREEMENT
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
DE
2012
LICENSE AGREEMENT
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2012
RESEARCH AND LICENSE AGREEMENT
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
WA
2011
FIRST AMENDMENT DATED AS OF JANUARY 29, 2009 TO DEVELOPMENT AND LICENSE AGREEMENT BY AND BETWEEN AMYLIN PHARMACEUTICALS, INC. AND MDRNA, INC. (formerly Nastech Pharmaceutical...
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2010
NON-EXCLUSIVE PATENT LICENSE AGREEMENT
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
NJ
2009
EX-10.1: PRODUCT DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2006
EXCLUSIVE DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
DC
2004